- Cellectar Biosciences $CLRB
- Kalvista Pharma $KALV
- Corbus Pharma [8-k] [Prospectus] $CRBP new ATM, plus new disclosures about intellectual property
- Tracon Pharma $TCON
- Rosette Genomics $ROSG
|Biotech Due Diligence||
Just like the online shopping deals, the holiday weekend bad news starting early this year with the Alzheimer's disease flop from Eli Lilly $LLY and the terrible safety news from Juno Therapeutics $JUNO. Nevertheless, as before, BiotechDueDiligence trolled the muddy waters of the Thanksgiving Eve and black Friday SEC filings for any interesting tidbits.
Your comment will be posted after it is approved.
Leave a Reply.